Photodynamic Therapy Market Expected to Advance with Next-Gen Light-Based Therapies

The global photodynamic therapy (PDT) market is poised for remarkable expansion in the coming years. Driven by technological advancements, increasing prevalence of chronic diseases, and growing adoption of minimally invasive treatments, the market is projected to reach US$3.7 billion in 2025 and surge to US$6.0 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.2% during the forecast period from 2025 to 2032. Photodynamic therapy, a treatment modality that combines photosensitizing agents with specific wavelengths of light to target abnormal cells, has gained significant traction across oncology and dermatology applications, making it a focal point for healthcare providers and investors alike.